Abridge vs Eleos Health (2026)
A health system with a behavioral health service line eventually asks whether its enterprise scribe covers it, and this is that question. Abridge is the deepest deployed documentation platform in the category, Best in KLAS in consecutive years across more than two hundred and fifty health systems, with a full trust centre and coverage spanning outpatient, inpatient and emergency care. Eleos is built only for behavioral health, including substance use treatment and field based care, and holds the strongest compliance stack in that lane with a published business associate agreement. The test is practical rather than philosophical: ask your general vendor to produce a psychiatric evaluation and a substance use encounter note from real audio. Most general scribes do not model those formats or the confidentiality rules attached to them, and that is what the specialist is selling.
- The adoption record is the deepest in the category, Best in KLAS in consecutive years across more than two hundred and fifty health systems, with a full trust centre and named sub processors.
- One documentation contract across the whole organisation is administratively simpler than an enterprise scribe plus a behavioral specialist.
- Coverage spans outpatient, inpatient and emergency settings with dozens of specialties, so most service lines are handled by the same product.
- It is built for behavioral health specifically, including substance use treatment and field based care, which have documentation structures and confidentiality rules general scribes do not model.
- The compliance stack is the strongest in this lane, with multiple audited certifications including the AI management standard and a published business associate agreement.
- Behavioral documentation carries protections beyond the general health privacy rule in many jurisdictions, and a product built for that context is a defensible choice when the note is later read in a licensure or legal proceeding.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Abridge and Eleos Health are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Abridge | Eleos Health |
|---|---|---|
| Primary category | Ambient Scribes | Behavioral Health AI |
| Founded | 2018 | 2019 |
| Headquarters | Pittsburgh, Pennsylvania | Boston, Massachusetts, United States |
| Website | abridge.com | eleos.health |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Abridge its top capability grade on several axes, including AI Centrality, Autonomy and Oversight Model and Model Supply Chain Disclosure. Set against Eleos Health, Abridge grades higher on Model Supply Chain Disclosure and AI Governance and Bias Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Eleos Health its top capability grade on several axes, including AI Centrality, Autonomy and Oversight Model and Clinical and Operational Evidence. Set against Abridge, Eleos Health grades higher on several axes, including AI Safety and PHI Stewardship, HIPAA and BAA Posture and FDA and Regulatory Status. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Abridge or Eleos Health?
On the axes where the AI Health Index separates them, Abridge grades higher on Model Supply Chain Disclosure and AI Governance and Bias Disclosure, and Eleos Health grades higher on several axes, including AI Safety and PHI Stewardship, HIPAA and BAA Posture and FDA and Regulatory Status. Eleos Health leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Abridge and Eleos Health differ most?
The widest separation the AI Health Index records between Abridge and Eleos Health is on Model Supply Chain Disclosure, where Abridge grades A and Eleos Health grades B. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do Abridge and Eleos Health grade the same?
The AI Health Index grades Abridge and Eleos Health the same on several axes, including AI Centrality, Autonomy and Oversight Model and Model and Technology Transparency. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Ambient Scribes page.
This is a scoping question rather than a head to head: the honest test is whether your enterprise scribe handles behavioral documentation formats, substance use confidentiality rules and the field based visit, and most do not model any of them. Ask your general vendor to demonstrate on a real psychiatric evaluation and a substance use encounter before assuming coverage. Neither vendor publishes a note accuracy figure.
Behavioral audio is the most sensitive recording in this index, and a general purpose scribe's retention and training terms were written for an outpatient office visit rather than for a therapy session.